Literature DB >> 7588954

Preparation of mono-radioiodinated tracers for study of the in vivo metabolism of atrial natriuretic peptide in humans.

A Clerico1, G Iervasi, C Manfredi, S Salvadori, M Marastoni, M G Del Chicca, D Giannessi, S Del Ry, M G Andreassi, L Sabatino.   

Abstract

In the present paper we evaluate the optimum chemical conditions for labelling atrial natriuretic peptide (ANP) and its metabolites and for preparing highly purified radiotracers which can be used for in vivo kinetic studies of ANP in humans. Synthetic alpha h1-28ANP and some hormone metabolites were iodinated with Na125I or Na131I by means of the lactoperoxidase (ANP) or the chloramine-T (ANP metabolites) technique. The biological activity of labelled ANP was tested by means of a binding study using mouse cardiac membranes. A high-performance liquid chromatography (HPLC) procedure was used to purify the labelled hormone and the principal labelled metabolites in venous plasma samples collected up to 50 min after the injection of 125I-labelled ANP from nine healthy men. The main ANP kinetic parameters were derived from the disappearance curves of the [125I]ANP, which were satisfactorily fitted by a biexponential function in all subjects. The main advantages of this tracer technique are: (1) high accuracy, allowing the identification of the metabolites produced in vivo under steady-state conditions after injection of the precursor (labelled hormone); (2) high sensitivity, allowing the detection of minimal quantities of metabolites (that cannot be identified on the basis of the integrated areas from the ultraviolet-absorbing peaks on HPLC); (3) high specificity, allowing the detection of possible in vitro artefactual generation of cleavage products of ANP using an internal labelled standard. Utilizing this tracer method, it was possible to estimate the principal parameters of ANP kinetics and also to plot the appearance curves of the labelled metabolites produced in vivo after the injection of the labelled precursor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588954     DOI: 10.1007/BF00808410

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

Review 1.  Atrial natriuretic peptide: synthesis, release, and metabolism.

Authors:  H Ruskoaho
Journal:  Pharmacol Rev       Date:  1992-12       Impact factor: 25.468

2.  Efficiency criteria in radioactivity counting.

Authors:  R LOEVINGER; M BERMAN
Journal:  Nucleonics       Date:  1951-07

3.  Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney.

Authors:  J L Sonnenberg; Y Sakane; A Y Jeng; J A Koehn; J A Ansell; L P Wennogle; R D Ghai
Journal:  Peptides       Date:  1988 Jan-Feb       Impact factor: 3.750

4.  Clearance and early hydrolysis of atrial natriuretic factor in vivo. Structural analysis of cleavage sites and design of an analogue that inhibits hormone cleavage.

Authors:  C L Condra; E A Leidy; P Bunting; C D Colton; R F Nutt; M Rosenblatt; J W Jacobs
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

5.  Quantitative and qualitative differences in muscarinic cholinergic receptors in embryonic and newborn chick hearts.

Authors:  M M Hosey; J Z Fields
Journal:  J Biol Chem       Date:  1981-06-25       Impact factor: 5.157

6.  Production and storage of (125-I) thyroxine and (125-I) triiodothyronine of high specific activity.

Authors:  J M Kjeld; S F Kuku; L Diamant; T R Fraser; G F Joplin; K Mashiter
Journal:  Clin Chim Acta       Date:  1975-06-20       Impact factor: 3.786

7.  Clearance function of type C receptors of atrial natriuretic factor in rats.

Authors:  F A Almeida; M Suzuki; R M Scarborough; J A Lewicki; T Maack
Journal:  Am J Physiol       Date:  1989-02

8.  ANP kinetics in normal men: in vivo measurement by a tracer method and correlation with sodium intake.

Authors:  G Iervasi; A Clerico; S Berti; A Pilo; F Vitek; A Biagini; M T Baratto; R Bianchi; L Donato
Journal:  Am J Physiol       Date:  1993-03

9.  Renal sites of action of physiological increases in plasma atrial natriuretic factor concentration in essential hypertension.

Authors:  N E Bruun; P Skøtt; J Giese
Journal:  J Hypertens       Date:  1992-01       Impact factor: 4.844

  9 in total
  2 in total

1.  Possibility of age regulation of the natriuretic peptide C-receptor in human platelets.

Authors:  D Giannessi; M G Andreassi; S Del Ry; A Clerico; M G Colombo; N Dini
Journal:  J Endocrinol Invest       Date:  2001-01       Impact factor: 4.256

2.  Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis.

Authors:  A Clerico; R Caprioli; S Del Ry; D Giannessi
Journal:  J Endocrinol Invest       Date:  2001-01       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.